Crescent Capital-owned Australian Clinical Labs seeks $315m in IPO

Australian Clinical Labs (ACL), a pathology provider owned by domestic private equity firm Crescent Capital Partners, is seeking to raise $315 million in an initial public offering next week, according to a memo seen by Reuters.